Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factors and Oncological Outcome Analysis of Retroperitoneal Sarcoma

NCT06612671 is registered in ClinicalTrials.gov with Taichung Veterans General Hospital as lead sponsor.

NCT NCT06612671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06612671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factors and Oncological Outcome Analysis of Retroperitoneal Sarcoma
Lead sponsor
Taichung Veterans General Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
October 1, 2023
Completion date
September 30, 2025
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retroperitoneal sarcoma